Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

February 20, 2018

Phase 3 Clinical Program Begins for Myovant’s Relugolix to Treat Endometriosis, Uterine Fibroids

News

Relugolix improved menstrual blood loss and pain associated with uterine fibroids, according to the results of two Japanese Phase 3 trials, Myovant Sciences announced. The results prompted a new Phase 3 ... Read more

February 14, 2018

Bladder DIE, a Form of Endometriosis, Not Caused by Adenomyosis, Study Suggests

News

Fewer than 50 percent of women with bladder deep infiltrating endometriosis (DIE) also carry a condition known as adenomyosis — the growth of endometrial cells into the muscle wall of the uterus. ... Read more

January 19, 2018January 19, 2018

Traditional Chinese Medicine Bushen Huoxue Shows Potential for Treating Endometriosis, Study Suggests

News

Traditional Chinese medicine Bushen Huoxue, an herbal infusion, is safe and may be as effective as Western medicine in treating endometriosis, a recent review study in China found. However, more ... Read more

December 18, 2017

Variations in 3 Genes Involved in Susceptibility, Severity of Endometriosis, Study Suggests

News

Researchers found that variations in three genes that provide instructions for immune cell receptors were linked to a higher susceptibility for endometriosis and disease progression. The study, “The impact of HLA-G, ... Read more

December 13, 2017

Rare Cancer in Surgery-Treated Endometriosis Patients is Aggressive, Slow-Growing, Review Reports

News

A rare, but aggressive, malignant transformation occurs at higher rates in endometriosis patients who underwent cesarean section, a review study shows. The phenomenon, known as endometriosis-associated malignant transformation in abdominal ... Read more

December 4, 2017December 4, 2017

Altered Gene Expression in Endometrium of Endometriosis Patients May Hint at Disease Pathways

News

Women with advanced endometriosis have alterations in their endometrium’s gene expression compared to healthy controls — a discovery that may provide hints to the mechanisms underlying the disease. The study, ... Read more

November 27, 2017August 20, 2018

Elagolix Shows Promise in Treating Symptoms of Both Endometriosis and Uterine Fibroids, Experts Say in Interview

News

Elagolix (ABT-620), being developed by AbbVie, is under review by the U.S. Food and Drug Administration (FDA) as a possible therapy for women with endometriosis and is in advanced clinical testing ... Read more

November 13, 2017November 13, 2017

Elagolix Improves Uterine Fibroid Symptoms with and Without Add-Back Therapy, Trials Show

News

AbbVie presented data from two Phase 2 clinical trials showing that elagolix, with or without add-back therapy, led to a rapid reduction of heavy menstrual bleeding compared to a placebo ... Read more

October 30, 2017October 30, 2017

AbbVie’s Elagolix Wins FDA Priority Review to Manage Endometriosis with Associated Pain

News

The U.S. Food and Drug Administration (FDA) has granted priority review to AbbVie’s investigational medicine, Elagolix — formerly known as ABT-620 — for managing endometriosis with associated pain. Elagolix is an oral gonadotropin-releasing ... Read more

September 18, 2017

Endometriosis Identified as Risk Factor for Pregnancy Complications

News

Women with endometriosis are at higher risk for complications during pregnancy, including a higher risk of premature birth, miscarriage, placenta previa, smaller newborns, and cesarean delivery, according to a recent ... Read more